Back to GALE Stock Lookup
Pages: 1 2 »» Last Page

Galena Biopharma (GALE) – Corporate News

Jun 13, 2016 07:06 AM Galena Biopharma (GALE) Announces Presentation of Encouraging GALE-401 Safety Data
Jun 10, 2016 02:52 PM Galena Biopharma (GALE) Receives FDA Orphan Drug Designations for Two FBP-Derived Cancer Immunotherapy Peptides
Jun 10, 2016 08:12 AM Galena Biopharma's (GALE) Treatment of Ovarian Cancer Receives FDA Orphan Drug Designation
Jun 6, 2016 02:02 PM Galena Biopharma (GALE) Announces Presentation of GALE-301 Phase 1/2a Data in Certain Cancers at ASCO
Jun 1, 2016 07:06 AM Galena Biopharma (GALE) Announces Receipt of FDA Fast-Track Designation for NeuVax Combo in Breast Cancer
May 18, 2016 05:51 PM Galena Biopharma (GALE) to Present the GALE-301 Phase 1/2a Primary Analysis at ASCO
Apr 26, 2016 07:09 AM Galena Biopharma (GALE) Names New Board Member
Apr 19, 2016 09:06 AM Galena Biopharma (GALE) Will Present GALE-301/GALE-302 Phase 1/2a Data at AACR 2016
Mar 29, 2016 07:07 AM Galena Biopharma (GALE) Reports NeuVax Phase 3, PRESENT Achieves Qualifying DFS Events
Mar 11, 2016 01:58 PM Galena Biopharma (GALE) Corrects Error in Form 10-K Regarding Investigation
Feb 8, 2016 07:37 AM Galena Biopharma (GALE) Receives Notice of Allowance of U.S. Patent for NeuVax
Jan 21, 2016 04:12 PM Galena Biopharma (GALE) Announces Presentation of Data in Gastric Cancer Patients at ASCO 2016 Gastrointestinal Cancers Symposium
Jan 13, 2016 07:12 AM Galena Biopharma (GALE) Offers Outlook for 2016; Expects to Meet Multiple Cancer Immunotherapy Milestones
Jan 6, 2016 04:26 PM Galena Biopharma (GALE) Plans Common Stock, Warrants Offering
Dec 30, 2015 07:22 AM Midatech Pharma (MTP) Announces Completion of Zuplenz Acquisition
Dec 29, 2015 09:03 AM Galena Biopharma (GALE) Announces Closing of Midatech Deal; Updates on Divestiture Costs
Dec 24, 2015 07:06 AM Galena Biopharma (GALE) Steven Kriegsman to Resign from Baord
Dec 22, 2015 04:44 PM Galena Biopharma (GALE) Discloses Receipt of Subpoena Related to ABSTRAL Marketing
Dec 18, 2015 06:40 AM Midatech Pharma to Acquire Galena's (GALE) Zuplenz in ~$29.75M Deal
Dec 8, 2015 07:08 AM Galena Biopharma (GALE)Presents GALE-401 Phase 2 POC Data; Efficacy Compared Favorably with Anagrelide IR
Dec 4, 2015 07:06 AM Galena Biopharma (GALE) Enters Class Action Settlement; Will Pay $20M
Nov 20, 2015 07:06 AM Galena Biopharma (GALE) Sells Abstral Tablet in $12M Deal
Nov 9, 2015 07:06 AM Galena Biopharma (GALE) Announces Presentation of GALE-301, GALE-302 Data
Oct 30, 2015 09:07 AM Galena Biopharma (GALE) Names Bijan Nejadnik as CMO
Sep 30, 2015 07:05 AM Galena Biopharma (GALE), NCI to Collaborate on NeuVax Phase 2 in DCIS
Sep 28, 2015 07:07 AM Galena Biopharma (GALE) Announces Presentation of GALE-301 Phase 2a Data at ERS Congress
Aug 24, 2015 07:13 AM Galena Biopharma (GALE) Announces IDMC Recommendation to Reduce Cardiac Toxicity Monitoring in Phase 3 PRESENT Trial
Jul 29, 2015 07:06 AM Galena Biopharma (GALE) Announces U.S. Launch of Zuplenz
Jun 15, 2015 07:09 AM Galena Biopharma (GALE) Announces Presentation of Encouraging GALE-401 Phase 2 Data in Thrombocytosis
May 27, 2015 07:16 AM Galena Biopharma (GALE) Reports Publication of NeuVax, GALE-301 Abstracts at ASCO
Apr 21, 2015 09:27 AM Galena Biopharma (GALE) Receives FDA Warning Letter Over Abstral Tablet Manufacturing
Apr 14, 2015 07:25 AM Galena Biopharma (GALE) Announces Completion of NeuVax Phase 3 PRESENT Enrollment
Apr 9, 2015 05:37 PM Galena Biopharma (GALE) Receives FDA Warning Letter, Not Expected to Impact Guidance
Mar 26, 2015 07:06 AM Galena Biopharma (GALE) Announces Enrollment Expansion of NeuVax Combo Phase 2b
Mar 13, 2015 09:24 AM Galena Biopharma (GALE) Prices 24.4M Common, Warrants Offering at $1.56/Unit
Feb 9, 2015 07:14 AM Galena Biopharma (GALE) Achieves 700 Patient Enrollment Milestone in NeuVax Phase 3 PRESENT
Feb 5, 2015 07:14 AM Galena Biopharma (GALE) Unit Files Patent Suit Against Actavis (ACT)
Jan 8, 2015 07:08 AM Galena Biopharma (GALE) Guides FY15 Below Consensus Expectations
Dec 11, 2014 08:38 AM Galena Biopharma (GALE) Presents Initial IHC Screening Data from NeuVax Phase 3 PRESENT
Dec 8, 2014 07:07 AM Galena Biopharma (GALE) Presents Phase 1, Prelim. Phase 2 GALE-401 Data at ASH
Dec 5, 2014 07:06 AM Galena Biopharma (GALE) Will Present IHC Data from NeuVax Phase 3 PRESENT at SABCS
Dec 2, 2014 07:11 AM Galena Biopharma (GALE) Receives NoA from USPTO for GALE-401 Patent App
Dec 1, 2014 07:06 AM Galena Biopharma (GALE) to Present GALE-401 Phase 1 Data at ASH
Nov 20, 2014 04:21 PM Galena Biopharma (GALE) Enters $55M Common Purchase Agreement with Lincoln Park Capital
Nov 18, 2014 07:06 AM Galena Biopharma (GALE) Reports Completion of GALE-401 Phase 2 Enrollment
Nov 11, 2014 08:54 AM Galena Biopharma (GALE) Comences Dosing in NeuVax Combo Phase 2 (RHHBY)
Nov 7, 2014 07:08 AM Galena Biopharma (GALE) Issues Encouraging Update on GALE-301 Phase 1/2a as Ovarian Cancer Treatment
Oct 14, 2014 07:06 AM Galena Biopharma (GALE) Receives NoA from Japanese Patent Office for NeuVax
Oct 8, 2014 07:06 AM Galena Biopharma (GALE) Receives NeuVax-Related Patent Notice of Allowance from USPTO
Sep 25, 2014 04:17 PM Galena Biopharma (GALE) Releases Special Committee Report
Pages: 1 2 »» Last Page

Back to GALE Stock Lookup